Athyrium Capital Management
Overview
Athyrium Capital is a specialized asset management company with a focus on the global healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.
Investment Focus
- Commercial-stage companies
- Compelling products
- Differentiated services
- Global presence
Portfolio Companies
Reach Athyrium Capital Management directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Athyrium Capital Management
What sectors does Athyrium Capital Management invest in?
Athyrium Capital Management invests in Healthcare Services, Medical Devices, Biopharmaceuticals and Healthcare Information Technology, and is based in New York, New York, United States. Athyrium Capital Management is listed as a private investment firm in the ConnectSafely investor database.
What stage does Athyrium Capital Management invest at?
Athyrium Capital Management backs companies at Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 25M - 150M.
Which regions does Athyrium Capital Management invest in?
Athyrium Capital Management invests across United States, Australia, Europe and Asia.
Who are the partners at Athyrium Capital Management?
Team members listed for Athyrium Capital Management include Elin Strong (Chief Financial Officer) and Paul Wakefield (Chief Financial Officer).
What companies has Athyrium Capital Management invested in?
Athyrium Capital Management's portfolio includes Crown Laboratories, Basilea Pharmaceutica, Calliditas Therapeutics, Choice Health At Home, Coherus Biosciences, Esperion Therapeutics and Unlock Health.
How do I contact Athyrium Capital Management?
Athyrium Capital Management's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
